Advances in telemedicine bridge the gap between rural and urban care delivery with timely, high quality and safe patient care. This reduces health disparities and costs while improving care.
-CEO Dick Govatski

17, August, 2015

Net Medical Xpress Announces Q2 Profitabilty

Positive Cash Flow and Strengthened Balance Sheet on Growing Telemedicine Services

17 August 2015 - Net Medical Xpress Solutions, Inc. (OTCQB SYMBOL: NMXS), a leader in the telemedicine field, announced today revenue for the second quarter of 2015 of $1,128,000 vs. revenue of $1,174,000 in the second quarter of 2014. The company reported net income of $29,000 or $0.00 per share versus a net loss of ($67,000) or $0.00 per share in the second quarter of last year.

For the first six months of 2015, Net Medical reported revenue of $2,368,000 vs. revenue of $2,445,000 in the first half of 2014. The company reported net income of $100,000 or $0.00 per share versus a net loss of ($76,000) or $0.00 per share in the first half of last year.

Dick Govatski, CEO, Net Medical, said, “The results of the second quarter and the first half of 2015 reflect substantial progress of our telemedicine programs and the increasing financial health of our company. This was underscored by the 161% revenue gain in our Specialists segment with strong performances in neurological services, primary care and hospital hardware sales. We are concentrating our efforts to grow this division to offset a temporary slowdown in our radiology and cardiological services where we face increasing competition resulting in pricing pressure.

“Our debt-free balance sheet showed healthy gains in assets and decreases in liabilities. For the first six months we generated $122,000 in cash from operating activities.

“Although our positive revenue performance was not uniform across all segments, our telemedicine programs are attracting increasing attention from a variety of potential partners. During the quarter we announced a new partnership with BioVentive to market telemedicine services to the healthcare industry throughout the United States. Over 100 sales representatives will market telemedicine products and services from BioVentive based on Net Medical technology and exclusive products and services from Net Medical including our Specialist Services as well as new BioVentive products based on Net Medical technology.

“We also signed an agreement with telehealth consultant group T4 to provide telemedicine services for up to 18 hospitals in Iraq, Saudi Arabia, Kuwait, Quatar, United Arab Emirates, and Kuwait and we introduced a new stroke program for rural hospitals in the U.S. We are currently installing our first integration between Net Medical’s X-REX telemedicine management program the CEREBROS™ stroke management program from Corazon at an Arizona hospital.

“A number of other ventures are in active discussion and we expect to have more news about these in the near future.

“Collectively these new programs have positioned us as an emerging world leader in telemedicine services. We have good reason to be optimistic about the second half of 2015 and 2016,” Govatski said.

Please contact Dick Govatski, president and CEO, at 505-255-1999 or ceo@nmxs.com for more detail.

04, August, 2015

Net Medical Partners With BioVentive to Market Telemedicine Services Nationally

Over 100 Reps to Open New Telemedicine Markets

04 August 2015 - Net Medical Xpress Solutions, Inc. (OTCQB SYMBOL: NMXS), a leader in the telemedicine field, announced today that it is partnering with BioVentive to market telemedicine services to the healthcare industry throughout the United States.

Over 100 sales representatives will market telemedicine products and services from BioVentive based on Net Medical technology and exclusive products and services from Net Medical, including the company's Specialist Services as well as new BioVentive products based on Net Medical technology.

Brett Nauta, CEO of BioVentive, said, “We are extremely pleased to partner with Net Medical Xpress to develop new products and markets for healthcare communications. Our management team believes the proprietary Net Medical technology platform offers expansion capabilities that can open new markets and solve the growing need for better access to quality healthcare. We selected Net Medical based on their proven experience using emerging medical communications technologies to provide high quality service to their customers. Their team's overwhelming emphasis and concern for positive patient outcomes was an important factor for us.”

Dick Govatski, CEO, Net Medical, said, “This is an exciting and significant expansion of our telemedicine activities in all 50 states. Net Medical will benefit several ways including revenue streams from new products created by BioVentive, the geographical expansion of marketing and sales of our successful hospital telemedicine program, and the sale of our proprietary telemedicine carts for use in these various services. We are delighted to partner with a company with the experience and expertise of BioVentive.”

For more information on BioVentive, Inc., please visit www.bioventive.com/.

Please contact Dick Govatski, president and CEO, at 505-255-1999 or ceo@nmxs.com for more detail.

Net Medical Xpress™ products and services are FDA cleared for specific clinical applications and are intended for research use for other applications.
©2015 Net Medical Xpress™ Inc. All Rights Reserved.